India, Oct. 4 -- image credit- shutterstock
Mumbai-based pharma major Lupin Limited has announced that its wholly owned subsidiary,Nanomi B.V., has signed a definitive agreement for the acquisition of VISUfarma B.V., a portfolio company of global healthcare specialist investor GHO Capital Partners LLP.
The acquisition of VISUfarma, with its broad portfolio of innovative eye health products and established commercial infrastructure, aligns with Lupin's strategy to expand its European business and footprint and to advance the company's global specialty franchise.
By integrating VISUfarma's established commercial operations, Lupin will tap into the attractive ophthalmology market, which is experiencing significant global growth driven by ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.